<SEC-DOCUMENT>0001485003-22-000154-index.html : 20221107 <SEC-HEADER>0001485003-22-000154.hdr.sgml : 20221107 <ACCEPTANCE-DATETIME>20221107080030 ACCESSION NUMBER: 0001485003-22-000154 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20221107 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221107 DATE AS OF CHANGE: 20221107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 221363775 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>sesnform3q2022earningsrele.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: sesnform3q2022earningsrele.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ex991_3q2022earningsrele.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: ex991_3q2022earningsrele.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>ex991_3q2022earningsrele001.jpg <TEXT> Document 3 - file: ex991_3q2022earningsrele001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ex991_3q2022earningsrele002.jpg <TEXT> Document 4 - file: ex991_3q2022earningsrele002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ex991_3q2022earningsrele003.jpg <TEXT> Document 5 - file: ex991_3q2022earningsrele003.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ex991_3q2022earningsrele004.jpg <TEXT> Document 6 - file: ex991_3q2022earningsrele004.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>ex991_3q2022earningsrele005.jpg <TEXT> Document 7 - file: ex991_3q2022earningsrele005.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>ex991_3q2022earningsrele006.jpg <TEXT> Document 8 - file: ex991_3q2022earningsrele006.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>ex991_3q2022earningsrele007.jpg <TEXT> Document 9 - file: ex991_3q2022earningsrele007.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>ex991_3q2022earningsrele008.jpg <TEXT> Document 10 - file: ex991_3q2022earningsrele008.jpg
</DOCUMENT> </SEC-DOCUMENT>